期刊文献+

血清锌水平与儿童特应性皮炎关系的初步探讨

Preliminary study on the relationship between serum zinc levels and atopic dermatitis in children
下载PDF
导出
摘要 目的:探讨锌缺乏与儿童特应性皮炎(atopic dermatitis,AD)发病的关系。方法:收集该院皮肤科门诊2012年3月—2014年9月就诊的62例AD患儿,并随机分为补锌组和常规治疗组(常规组),健康对照组为50例体检的健康儿童。治疗前、后检测血清锌及IgE水平,应用湿疹面积和严重程度指数评分(EASI)、视觉模拟评分法(VAS)及欧洲特应性皮炎评分标准(SCORAD)对AD患儿病情进行评价。结果:治疗前AD患儿血清锌浓度显著低于健康对照组(P=0.015),但总IgE水平显著升高(P=0.023)。治疗后,补锌组患儿血清锌水平显著高于常规组;治疗8周后,补锌组及常规组血清总IgE水平分别为(62.78±13.79)k U/L和(119.68±15.89)k U/L,健康对照组为(56.82±24.65)k U/L,差异具有统计学意义(P<0.05)。治疗后4周及8周,补锌组与常规组EASI、VAS及SCORAD评分比较,差异有统计学意义(P<0.05);且补锌组治疗后8周与治疗前比较,差异亦有统计学意义(P<0.05)。结论:血清锌含量的降低可能是AD发病的重要原因之一,口服补锌可以改善AD的临床症状,是AD治疗的重要手段之一。 Objective: To explore the relationship between serum zinc levels and atopic dermatitis (AD) in children. Methods: From March 2012 to September 2014, 62 children with AD were randomly divided into two groups (zinc supplemental and non zinc supplemental group). 50 healthy children served as normal controls. Eczema assessment severity index (EASI), visual ana- logue scale (VAS), scoring atopic dermatitis (SCORAD), serum zinc and IgE levels were assessed before and after treatment. Results: In comparison with normal controls, the baseline zinc levels were significantly lower in AD patients (P=0.015), while the total IgE levels were higher (P=0.023). After zinc supplement, serum zinc levels in zinc supplemental group were higher than that in non zinc supplemental group. After 8 weeks of treatment, the total IgE levels differed significantly among three groups (62.78±13.79 kU/L in zinc supplemental group; 119.68±15.89kU/L in non supplemental group, and 56.82±24.65 kU/L in normal controls, P〈0.05 between groups). After 4 weeks and 8 weeks of treatment, the differences of EASI, VAS and SCORAD were significant between zinc supplemental and non zinc supplemental group (P〈0.05). Moreover, after 8 weeks of zinc supplement, EASI, VAS and SCORAD were markedly improved from baseline (P〈0.05). Conclusions: Zinc deficiency may be a risk factor for AD. Oral zinc suoolement can imnrove the clinical svmotoms of AD. It is an notional regimen for AD.
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2015年第7期413-416,共4页 Journal of Clinical Dermatology
关键词 特应性皮炎 血清锌 免疫球蛋白E atopic dermatitis serum zinc IgE
  • 相关文献

参考文献16

  • 1Xu F, Yan S, Li F, et al. Prevalence of childhood atopic der- matitis: an urban and rural community-based study in Shanghai, China[J]. PLoS One, 2012, 7(5): e36174.
  • 2王鹤飞,柏冰雪.特应性皮炎患者的皮肤屏障功能障碍[J].临床皮肤科杂志,2013,42(11):702-704. 被引量:9
  • 3Divekar R, Kita H.Recent advances in epithelium-derived cy- tokines (IL-33, IL-25, and thymic stromal lymphopoietin) and allergic inflammation[J]. Curr Opin Allergy Clin Immunol, 2015, 15(1): 98-103.
  • 4Thyssen JP, McFadden JP, Kimber I. The multiple factors affect- ing the association between atopic dermatitis and contact sensiti- zation[J]. Allergy, 2014, 69(1): 28-36.
  • 5Sidbury R, Tom WL, Bergman JN, et at.Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches[J]. J Am Acad Dermatol, 2014, 71(6): 1218-1233.
  • 6中华医学会皮肤性病学分会免疫学组特应性皮炎协作研究中心.中国特应性皮炎诊疗指南(2014版)[J].中华皮肤科杂志,2014,47(71:511-514.
  • 7常晶,张悦,张丽,韩秀萍.特应性皮炎患者外周血单个核细胞Toll样受体2、4表达研究[J].临床皮肤科杂志,2014,43(7):412-414. 被引量:6
  • 8Prasad AS. Zinc in human health: effect of zinc on immune cells[J]. Mol Med, 2008, 14(5-6): 353-357.
  • 9Maggini S, Wenzlaff S, Hornig D. Essential role of vitamin C and zinc in child immunity and health[J]. J Int Med Res, 2010, 38(2): 386-414.
  • 10Kim JE, Yoo SR, Jeong MG, et al. Hair zinc levels and the ef- ficacy of oral zinc supplementation in patients with atopic der- matitis[J]. Acta Derm Venereol, 2014, 94(5): 558-562.

二级参考文献31

  • 1谢志强,刘玲玲,窦霞,闻卫兢,王娣,赵俊郁,朱学骏.特应性皮炎皮损角质形成细胞TLR2和TLR4的表达[J].中国麻风皮肤病杂志,2006,22(1):23-25. 被引量:5
  • 2Addor FA, Aoki V. Skin barrier in atopic dermatitis[J]. An BrasDermatol, 2010, 85(2): 184-194.
  • 3Olah A, Szollosi AG, Biro T. The channel physiology of the skin[J]. Rev Physiol Biochem Pharmacol, 2012, 163: 65-131.
  • 4Sajic D, Asiniwasis R, Skotnicki-Grant S. A look at epidermalbarrier function in atopic dermatitis: physiologic lipid replace-ment and the role of ceramides[J]. Skin Therapy Lett, 2012, 17(7): 6-9.
  • 5Heimall J, Spergel JM. Filaggrin mutations and atopy: conse-quences for future therapeutics [J]. Expert Rev Clin Immunol,2012,8(2): 189-197.
  • 6Tokura Y. Extrinsic and intrinsic types of atopic dermatitisfj]. JDermatol Sci, 2010, 58(4): 1-7.
  • 7de Koning HD, van den Bogaard EH, Bergboer JG,et al. Expres-sion profile of comified envelope structural proteins and ker-atinocyte differentiation -regulating proteins during skin barrierrepaiifj]. Br J Dermatol, 2012,166(6): 1245-1254.
  • 8Fortugno P, Furio L, Teson M, et al. The 420K LEKTI variantalters LEKTI proteolytic activation and results in protease dereg-ulation: implications for atopic dermatitis [J]. Hum Mol Genet,2012,21(19): 4187-4200.
  • 9Rawlings AV, Voegeli R. Stratum coraeum proteases and dryskin conditions[J]. Cell Tissue Res, 2013, 351(2): 217-235.
  • 10Sawada E, Yoshida N, Sugiura A, et al. Thl cytokines accentuatebut Th2 cytokines attenuate ceramide production in the stratumcomeum of human epidermal equivalents: an implication for thedisrupted barrier mechanism in atopic dermatitis [J]. J DermatolSci, 2012, 68(1): 25-35.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部